GlassScriptPhysician profile
James C Tsai
NPI 1336226588
$6,963.86
in general payments reported to CMS, 2019-2025
13 companies · $712 in 2025
The $712 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,851 · 2020: $46.53 · 2022: $61.77 · 2023: $3,116 · 2024: $176 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,875 · Food and Beverage: $1,379 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,875.00 |
| Food and Beverage | $1,379.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,219.13 | 2019 | |
| Thea Pharma INC. | $1,989.17 | 2022-2025 | Iyuzeh |
| Bausch & Lomb Americas INC. | $1,077.39 | 2023-2024 | Vyzulta, Xipere, Lotemax |
| Abbvie INC. | $630.39 | 2023-2025 | Xen Glaucoma Treatment System |
| Aerie Pharmaceuticals, INC. | $575.00 | 2019 | |
| Alcon Vision LLC | $153.62 | 2019-2025 | Unity, Simbrinza, Rhopressa |
| New World Medical,INC. | $87.80 | 2023 | |
| Sight Sciences, INC. | $79.05 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Beaver-Visitec International, INC. | $45.88 | 2025 | |
| Ocular Therapeutix, INC. | $37.30 | 2022 | |
| Bausch Health US, LLC | $27.13 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $22.60 | 2024 | Xdemvy |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.